3-Chloromethamphetamine
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C10H14ClN |
Molar mass | 183.68 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Chloromethamphetamine (3-CMA, MCMA) is a substituted amphetamine derivative invented in the 1960s. In animal studies it was deemed to be a "hallucinogen" rather than a stimulant, though the assays used at the time did not distinguish between the compounds now termed psychedelics and those now termed empathogens.[1][2][3]
See also
- 3-Chloroamphetamine
- 3-Chloromethcathinone
- 4-Chloromethamphetamine
- 3-Fluoromethamphetamine
- 3-Methoxymethamphetamine
- 5-Cl-bk-MPA
- Fenfluramine
References
- ^ Knoll J, Vizi ES, Ecseri Z (February 1966). "Psychomimetic methylamphetamine derivatives". Archives Internationales de Pharmacodynamie et de Therapie. 159 (2): 442–51. PMID 5916746.
- ^ Brimblecombe RW, Pinder RM (1975). Hallucinogenic agents. Wright-Scientechnica. pp. 71–74. ISBN 978-0-85608-011-1.
- ^ Segawa H, T Iwata Y, Yamamuro T, Kuwayama K, Tsujikawa K, Kanamori T, Inoue H (March 2017). "Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography". Drug Testing and Analysis. 9 (3): 389–398. doi:10.1002/dta.2040. PMID 27383263.